nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Vandetanib—thyroid cancer	0.135	0.175	CbGbCtD
Nelfinavir—ABCG2—Sorafenib—thyroid cancer	0.0817	0.105	CbGbCtD
Nelfinavir—CYP3A7—Sorafenib—thyroid cancer	0.0603	0.0778	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0603	0.0778	CbGbCtD
Nelfinavir—CYP2B6—Sorafenib—thyroid cancer	0.0574	0.0741	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—thyroid cancer	0.0496	0.0639	CbGbCtD
Nelfinavir—CYP3A5—Sorafenib—thyroid cancer	0.0452	0.0584	CbGbCtD
Nelfinavir—CYP2C19—Sorafenib—thyroid cancer	0.0365	0.0471	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—thyroid cancer	0.0349	0.045	CbGbCtD
Nelfinavir—CYP1A2—Sorafenib—thyroid cancer	0.0337	0.0435	CbGbCtD
Nelfinavir—CYP2C9—Sorafenib—thyroid cancer	0.0303	0.0392	CbGbCtD
Nelfinavir—ABCB1—Sorafenib—thyroid cancer	0.0294	0.038	CbGbCtD
Nelfinavir—CYP3A4—Vandetanib—thyroid cancer	0.0293	0.0378	CbGbCtD
Nelfinavir—CYP2D6—Sorafenib—thyroid cancer	0.0277	0.0358	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—thyroid cancer	0.0179	0.0231	CbGbCtD
Nelfinavir—CYP3A4—Sorafenib—thyroid cancer	0.0176	0.0228	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—thyroid cancer	0.0168	0.0217	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—thyroid cancer	0.0107	0.0138	CbGbCtD
Nelfinavir—Mitiglinide—PPARG—thyroid cancer	0.00383	1	CrCbGaD
Nelfinavir—Muscle spasms—Vandetanib—thyroid cancer	0.00115	0.00522	CcSEcCtD
Nelfinavir—Urine abnormality—Doxorubicin—thyroid cancer	0.00114	0.00518	CcSEcCtD
Nelfinavir—Pancreatitis—Sorafenib—thyroid cancer	0.00114	0.00516	CcSEcCtD
Nelfinavir—Myasthenia—Epirubicin—thyroid cancer	0.00109	0.00493	CcSEcCtD
Nelfinavir—Folliculitis—Epirubicin—thyroid cancer	0.00109	0.00493	CcSEcCtD
Nelfinavir—Neutropenia—Sorafenib—thyroid cancer	0.00109	0.00492	CcSEcCtD
Nelfinavir—Urine analysis abnormal—Doxorubicin—thyroid cancer	0.00108	0.00488	CcSEcCtD
Nelfinavir—Pneumonia—Sorafenib—thyroid cancer	0.00104	0.00472	CcSEcCtD
Nelfinavir—Convulsion—Vandetanib—thyroid cancer	0.00104	0.00471	CcSEcCtD
Nelfinavir—Arthralgia—Vandetanib—thyroid cancer	0.00102	0.00463	CcSEcCtD
Nelfinavir—Anxiety—Vandetanib—thyroid cancer	0.00102	0.00461	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00101	0.00459	CcSEcCtD
Nelfinavir—Stomatitis—Sorafenib—thyroid cancer	0.00101	0.00457	CcSEcCtD
Nelfinavir—Jaundice—Sorafenib—thyroid cancer	0.00101	0.00457	CcSEcCtD
Nelfinavir—Folliculitis—Doxorubicin—thyroid cancer	0.00101	0.00456	CcSEcCtD
Nelfinavir—Myasthenia—Doxorubicin—thyroid cancer	0.00101	0.00456	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000979	0.00444	CcSEcCtD
Nelfinavir—Oedema—Vandetanib—thyroid cancer	0.000979	0.00443	CcSEcCtD
Nelfinavir—Epistaxis—Sorafenib—thyroid cancer	0.000976	0.00442	CcSEcCtD
Nelfinavir—Thrombocytopenia—Vandetanib—thyroid cancer	0.000958	0.00434	CcSEcCtD
Nelfinavir—Skin disorder—Vandetanib—thyroid cancer	0.000951	0.00431	CcSEcCtD
Nelfinavir—Hyperlipidaemia—Epirubicin—thyroid cancer	0.000949	0.0043	CcSEcCtD
Nelfinavir—Haemoglobin—Sorafenib—thyroid cancer	0.000934	0.00423	CcSEcCtD
Nelfinavir—Haemorrhage—Sorafenib—thyroid cancer	0.000929	0.00421	CcSEcCtD
Nelfinavir—Connective tissue disorder—Sorafenib—thyroid cancer	0.000913	0.00414	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000892	0.00404	CcSEcCtD
Nelfinavir—Insomnia—Vandetanib—thyroid cancer	0.000885	0.00401	CcSEcCtD
Nelfinavir—Paraesthesia—Vandetanib—thyroid cancer	0.000879	0.00398	CcSEcCtD
Nelfinavir—Erythema multiforme—Sorafenib—thyroid cancer	0.000879	0.00398	CcSEcCtD
Nelfinavir—Hyperlipidaemia—Doxorubicin—thyroid cancer	0.000878	0.00398	CcSEcCtD
Nelfinavir—Dyspnoea—Vandetanib—thyroid cancer	0.000873	0.00395	CcSEcCtD
Nelfinavir—Dyspepsia—Vandetanib—thyroid cancer	0.000862	0.0039	CcSEcCtD
Nelfinavir—Decreased appetite—Vandetanib—thyroid cancer	0.000851	0.00385	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000845	0.00383	CcSEcCtD
Nelfinavir—Angiopathy—Sorafenib—thyroid cancer	0.000843	0.00382	CcSEcCtD
Nelfinavir—Immune system disorder—Sorafenib—thyroid cancer	0.000839	0.0038	CcSEcCtD
Nelfinavir—Pain—Vandetanib—thyroid cancer	0.000837	0.00379	CcSEcCtD
Nelfinavir—Malnutrition—Sorafenib—thyroid cancer	0.000809	0.00366	CcSEcCtD
Nelfinavir—Erythema—Sorafenib—thyroid cancer	0.000809	0.00366	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0008	0.00363	CcSEcCtD
Nelfinavir—Muscle spasms—Sorafenib—thyroid cancer	0.000778	0.00352	CcSEcCtD
Nelfinavir—Abdominal pain—Vandetanib—thyroid cancer	0.000774	0.0035	CcSEcCtD
Nelfinavir—Body temperature increased—Vandetanib—thyroid cancer	0.000774	0.0035	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000752	0.00341	CcSEcCtD
Nelfinavir—Anaemia—Sorafenib—thyroid cancer	0.000748	0.00339	CcSEcCtD
Nelfinavir—Hyperuricaemia—Epirubicin—thyroid cancer	0.000737	0.00334	CcSEcCtD
Nelfinavir—Leukopenia—Sorafenib—thyroid cancer	0.000724	0.00328	CcSEcCtD
Nelfinavir—Inflammation—Epirubicin—thyroid cancer	0.000705	0.00319	CcSEcCtD
Nelfinavir—Asthenia—Vandetanib—thyroid cancer	0.000702	0.00318	CcSEcCtD
Nelfinavir—Blood uric acid increased—Epirubicin—thyroid cancer	0.000696	0.00315	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000696	0.00315	CcSEcCtD
Nelfinavir—Pruritus—Vandetanib—thyroid cancer	0.000692	0.00314	CcSEcCtD
Nelfinavir—Arthralgia—Sorafenib—thyroid cancer	0.000689	0.00312	CcSEcCtD
Nelfinavir—Myalgia—Sorafenib—thyroid cancer	0.000689	0.00312	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000684	0.0031	CcSEcCtD
Nelfinavir—Hyperuricaemia—Doxorubicin—thyroid cancer	0.000682	0.00309	CcSEcCtD
Nelfinavir—Diarrhoea—Vandetanib—thyroid cancer	0.00067	0.00303	CcSEcCtD
Nelfinavir—Inflammation—Doxorubicin—thyroid cancer	0.000652	0.00296	CcSEcCtD
Nelfinavir—Dizziness—Vandetanib—thyroid cancer	0.000647	0.00293	CcSEcCtD
Nelfinavir—Thrombocytopenia—Sorafenib—thyroid cancer	0.000646	0.00293	CcSEcCtD
Nelfinavir—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000644	0.00292	CcSEcCtD
Nelfinavir—Skin disorder—Sorafenib—thyroid cancer	0.000641	0.00291	CcSEcCtD
Nelfinavir—Anorexia—Sorafenib—thyroid cancer	0.000629	0.00285	CcSEcCtD
Nelfinavir—Vomiting—Vandetanib—thyroid cancer	0.000622	0.00282	CcSEcCtD
Nelfinavir—Rash maculo-papular—Epirubicin—thyroid cancer	0.000622	0.00282	CcSEcCtD
Nelfinavir—Mouth ulceration—Epirubicin—thyroid cancer	0.000618	0.0028	CcSEcCtD
Nelfinavir—Rash—Vandetanib—thyroid cancer	0.000617	0.0028	CcSEcCtD
Nelfinavir—Dermatitis—Vandetanib—thyroid cancer	0.000617	0.00279	CcSEcCtD
Nelfinavir—Headache—Vandetanib—thyroid cancer	0.000613	0.00278	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000602	0.00272	CcSEcCtD
Nelfinavir—Dyspnoea—Sorafenib—thyroid cancer	0.000589	0.00267	CcSEcCtD
Nelfinavir—Nausea—Vandetanib—thyroid cancer	0.000581	0.00263	CcSEcCtD
Nelfinavir—Dyspepsia—Sorafenib—thyroid cancer	0.000581	0.00263	CcSEcCtD
Nelfinavir—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000575	0.00261	CcSEcCtD
Nelfinavir—Decreased appetite—Sorafenib—thyroid cancer	0.000574	0.0026	CcSEcCtD
Nelfinavir—Mouth ulceration—Doxorubicin—thyroid cancer	0.000572	0.00259	CcSEcCtD
Nelfinavir—Diabetes mellitus—Epirubicin—thyroid cancer	0.000571	0.00259	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00057	0.00258	CcSEcCtD
Nelfinavir—Pain—Sorafenib—thyroid cancer	0.000565	0.00256	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00054	0.00245	CcSEcCtD
Nelfinavir—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000528	0.00239	CcSEcCtD
Nelfinavir—Urticaria—Sorafenib—thyroid cancer	0.000525	0.00238	CcSEcCtD
Nelfinavir—Body temperature increased—Sorafenib—thyroid cancer	0.000522	0.00236	CcSEcCtD
Nelfinavir—Abdominal pain—Sorafenib—thyroid cancer	0.000522	0.00236	CcSEcCtD
Nelfinavir—Dermatitis bullous—Epirubicin—thyroid cancer	0.000519	0.00235	CcSEcCtD
Nelfinavir—Hypoglycaemia—Epirubicin—thyroid cancer	0.000509	0.0023	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000496	0.00225	CcSEcCtD
Nelfinavir—Migraine—Epirubicin—thyroid cancer	0.000489	0.00221	CcSEcCtD
Nelfinavir—Affect lability—Epirubicin—thyroid cancer	0.000489	0.00221	CcSEcCtD
Nelfinavir—Hypersensitivity—Sorafenib—thyroid cancer	0.000486	0.0022	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000481	0.00218	CcSEcCtD
Nelfinavir—Asthenia—Sorafenib—thyroid cancer	0.000474	0.00215	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000471	0.00213	CcSEcCtD
Nelfinavir—Mood swings—Epirubicin—thyroid cancer	0.00047	0.00213	CcSEcCtD
Nelfinavir—Pruritus—Sorafenib—thyroid cancer	0.000467	0.00212	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—thyroid cancer	0.000462	0.00209	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000459	0.00208	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—thyroid cancer	0.000458	0.00208	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—thyroid cancer	0.000453	0.00205	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—thyroid cancer	0.000452	0.00205	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—thyroid cancer	0.000452	0.00205	CcSEcCtD
Nelfinavir—Diarrhoea—Sorafenib—thyroid cancer	0.000452	0.00205	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000447	0.00203	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—thyroid cancer	0.000438	0.00198	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000438	0.00198	CcSEcCtD
Nelfinavir—Dizziness—Sorafenib—thyroid cancer	0.000437	0.00198	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—thyroid cancer	0.000435	0.00197	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—thyroid cancer	0.000432	0.00196	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—thyroid cancer	0.000427	0.00194	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000424	0.00192	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—thyroid cancer	0.000421	0.00191	CcSEcCtD
Nelfinavir—Vomiting—Sorafenib—thyroid cancer	0.00042	0.0019	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00042	0.0019	CcSEcCtD
Nelfinavir—Rash—Sorafenib—thyroid cancer	0.000416	0.00189	CcSEcCtD
Nelfinavir—Dermatitis—Sorafenib—thyroid cancer	0.000416	0.00188	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000414	0.00187	CcSEcCtD
Nelfinavir—Headache—Sorafenib—thyroid cancer	0.000414	0.00187	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—thyroid cancer	0.000405	0.00184	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000405	0.00184	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—thyroid cancer	0.000401	0.00182	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—thyroid cancer	0.0004	0.00181	CcSEcCtD
Nelfinavir—Nausea—Sorafenib—thyroid cancer	0.000392	0.00178	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—thyroid cancer	0.000389	0.00176	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000387	0.00175	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—thyroid cancer	0.000385	0.00174	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—thyroid cancer	0.000373	0.00169	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—thyroid cancer	0.000373	0.00169	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—thyroid cancer	0.000371	0.00168	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—thyroid cancer	0.000367	0.00166	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000362	0.00164	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—thyroid cancer	0.000361	0.00163	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—thyroid cancer	0.000359	0.00163	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000358	0.00162	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—thyroid cancer	0.000356	0.00161	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—thyroid cancer	0.000345	0.00156	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—thyroid cancer	0.000345	0.00156	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—thyroid cancer	0.000345	0.00156	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—thyroid cancer	0.000344	0.00156	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—thyroid cancer	0.000343	0.00156	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—thyroid cancer	0.000343	0.00156	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—thyroid cancer	0.000341	0.00154	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—thyroid cancer	0.000339	0.00154	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—thyroid cancer	0.000337	0.00153	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000335	0.00152	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—thyroid cancer	0.000334	0.00151	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—thyroid cancer	0.000332	0.0015	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—thyroid cancer	0.000325	0.00147	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—thyroid cancer	0.000321	0.00145	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—thyroid cancer	0.000319	0.00145	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—thyroid cancer	0.000319	0.00144	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—thyroid cancer	0.000318	0.00144	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—thyroid cancer	0.000318	0.00144	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—thyroid cancer	0.000315	0.00143	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000312	0.00141	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—thyroid cancer	0.000312	0.00141	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—thyroid cancer	0.00031	0.00141	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—thyroid cancer	0.0003	0.00136	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—thyroid cancer	0.000299	0.00135	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—thyroid cancer	0.000299	0.00135	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—thyroid cancer	0.000297	0.00135	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—thyroid cancer	0.000295	0.00133	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—thyroid cancer	0.000289	0.00131	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—thyroid cancer	0.000288	0.00131	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—thyroid cancer	0.000287	0.0013	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—thyroid cancer	0.000287	0.0013	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—thyroid cancer	0.000277	0.00126	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—thyroid cancer	0.000277	0.00125	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—thyroid cancer	0.000277	0.00125	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—thyroid cancer	0.000276	0.00125	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—thyroid cancer	0.000275	0.00124	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—thyroid cancer	0.000273	0.00123	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—thyroid cancer	0.00027	0.00122	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—thyroid cancer	0.000268	0.00121	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—thyroid cancer	0.000268	0.00121	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—thyroid cancer	0.000266	0.0012	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—thyroid cancer	0.000259	0.00117	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000257	0.00116	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—thyroid cancer	0.000256	0.00116	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—thyroid cancer	0.000255	0.00115	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—thyroid cancer	0.000255	0.00115	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—thyroid cancer	0.000254	0.00115	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—thyroid cancer	0.000254	0.00115	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000253	0.00115	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—thyroid cancer	0.000251	0.00114	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—thyroid cancer	0.000249	0.00113	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—thyroid cancer	0.000248	0.00112	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—thyroid cancer	0.000244	0.00111	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—thyroid cancer	0.00024	0.00109	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—thyroid cancer	0.000239	0.00108	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—thyroid cancer	0.000237	0.00107	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—thyroid cancer	0.000236	0.00107	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—thyroid cancer	0.000236	0.00107	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—thyroid cancer	0.000236	0.00107	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—thyroid cancer	0.000235	0.00106	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000234	0.00106	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—thyroid cancer	0.000233	0.00105	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—thyroid cancer	0.000233	0.00105	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—thyroid cancer	0.000226	0.00102	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000222	0.00101	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000221	0.001	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—thyroid cancer	0.000221	0.001	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—thyroid cancer	0.000219	0.000993	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—thyroid cancer	0.000219	0.000993	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000218	0.000989	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—thyroid cancer	0.000218	0.000985	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—thyroid cancer	0.000217	0.000983	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—thyroid cancer	0.000215	0.000975	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—thyroid cancer	0.000215	0.000973	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—thyroid cancer	0.000212	0.000961	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000211	0.000954	CcSEcCtD
Nelfinavir—Pain—Epirubicin—thyroid cancer	0.000209	0.000945	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000206	0.000932	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—thyroid cancer	0.000204	0.000925	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—thyroid cancer	0.000203	0.000918	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—thyroid cancer	0.000201	0.000912	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—thyroid cancer	0.000201	0.000911	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—thyroid cancer	0.000201	0.000909	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.0002	0.000904	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—thyroid cancer	0.000199	0.0009	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—thyroid cancer	0.000196	0.000889	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000195	0.000883	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—thyroid cancer	0.000194	0.000878	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—thyroid cancer	0.000193	0.000875	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—thyroid cancer	0.000193	0.000874	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—thyroid cancer	0.000193	0.000874	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—thyroid cancer	0.000186	0.000843	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000185	0.000836	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—thyroid cancer	0.00018	0.000814	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—thyroid cancer	0.000179	0.000812	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—thyroid cancer	0.000178	0.000808	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—thyroid cancer	0.000178	0.000808	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—thyroid cancer	0.000175	0.000793	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—thyroid cancer	0.000173	0.000782	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—thyroid cancer	0.000167	0.000756	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—thyroid cancer	0.000166	0.000754	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—thyroid cancer	0.000162	0.000734	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—thyroid cancer	0.000161	0.000731	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—thyroid cancer	0.00016	0.000724	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—thyroid cancer	0.000155	0.000703	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—thyroid cancer	0.000154	0.0007	CcSEcCtD
Nelfinavir—Rash—Epirubicin—thyroid cancer	0.000154	0.000697	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—thyroid cancer	0.000154	0.000696	CcSEcCtD
Nelfinavir—Headache—Epirubicin—thyroid cancer	0.000153	0.000692	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—thyroid cancer	0.000149	0.000676	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—thyroid cancer	0.000145	0.000657	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—thyroid cancer	0.000144	0.00065	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—thyroid cancer	0.000142	0.000645	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—thyroid cancer	0.000142	0.000644	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—thyroid cancer	0.000141	0.000641	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—thyroid cancer	0.000134	0.000607	CcSEcCtD
Nelfinavir—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	2.56e-06	0.00513	CbGpPWpGaD
Nelfinavir—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	2.52e-06	0.00504	CbGpPWpGaD
Nelfinavir—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	2.45e-06	0.00492	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—CP—thyroid cancer	2.39e-06	0.0048	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	2.39e-06	0.0048	CbGpPWpGaD
Nelfinavir—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.37e-06	0.00475	CbGpPWpGaD
Nelfinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.28e-06	0.00456	CbGpPWpGaD
Nelfinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	2.26e-06	0.00454	CbGpPWpGaD
Nelfinavir—CYP3A7—Biological oxidations—RXRA—thyroid cancer	2.25e-06	0.00451	CbGpPWpGaD
Nelfinavir—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.18e-06	0.00437	CbGpPWpGaD
Nelfinavir—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.16e-06	0.00433	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—MINPP1—thyroid cancer	2.11e-06	0.00422	CbGpPWpGaD
Nelfinavir—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	2.1e-06	0.0042	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	2.05e-06	0.00411	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	1.96e-06	0.00393	CbGpPWpGaD
Nelfinavir—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.85e-06	0.0037	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—MINPP1—thyroid cancer	1.8e-06	0.00361	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	1.79e-06	0.00359	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.79e-06	0.00359	CbGpPWpGaD
Nelfinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.76e-06	0.00352	CbGpPWpGaD
Nelfinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.75e-06	0.0035	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CHST14—thyroid cancer	1.68e-06	0.00338	CbGpPWpGaD
Nelfinavir—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.68e-06	0.00336	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—MINPP1—thyroid cancer	1.67e-06	0.00334	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.67e-06	0.00334	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	1.67e-06	0.00334	CbGpPWpGaD
Nelfinavir—CYP2B6—Biological oxidations—RXRA—thyroid cancer	1.67e-06	0.00334	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—MINPP1—thyroid cancer	1.65e-06	0.00331	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.64e-06	0.00328	CbGpPWpGaD
Nelfinavir—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.63e-06	0.00326	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—MINPP1—thyroid cancer	1.54e-06	0.00308	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	1.53e-06	0.00307	CbGpPWpGaD
Nelfinavir—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.53e-06	0.00307	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CHST14—thyroid cancer	1.44e-06	0.00289	CbGpPWpGaD
Nelfinavir—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.42e-06	0.00285	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	1.42e-06	0.00285	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.42e-06	0.00285	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NDUFA13—thyroid cancer	1.42e-06	0.00284	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NDUFA13—thyroid cancer	1.41e-06	0.00282	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.4e-06	0.00281	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	1.4e-06	0.0028	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—HPGD—thyroid cancer	1.36e-06	0.00272	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.34e-06	0.00268	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CHST14—thyroid cancer	1.33e-06	0.00267	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CHST14—thyroid cancer	1.32e-06	0.00265	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.32e-06	0.00264	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	1.32e-06	0.00264	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NDUFA13—thyroid cancer	1.31e-06	0.00262	CbGpPWpGaD
Nelfinavir—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.31e-06	0.00262	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.3e-06	0.0026	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—RXRA—thyroid cancer	1.26e-06	0.00252	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.25e-06	0.0025	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CHST14—thyroid cancer	1.23e-06	0.00247	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MINPP1—thyroid cancer	1.22e-06	0.00245	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.22e-06	0.00244	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.22e-06	0.00244	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.22e-06	0.00244	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	1.22e-06	0.00244	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.2e-06	0.0024	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.2e-06	0.0024	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—HPGD—thyroid cancer	1.16e-06	0.00233	CbGpPWpGaD
Nelfinavir—CYP2D6—Biological oxidations—RXRA—thyroid cancer	1.16e-06	0.00232	CbGpPWpGaD
Nelfinavir—CYP2C9—Biological oxidations—RXRA—thyroid cancer	1.15e-06	0.0023	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.14e-06	0.00229	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.13e-06	0.00226	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.1e-06	0.00221	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.09e-06	0.00218	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—HPGD—thyroid cancer	1.08e-06	0.00215	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.07e-06	0.00214	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—HPGD—thyroid cancer	1.07e-06	0.00214	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.05e-06	0.0021	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.04e-06	0.00209	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NDUFA13—thyroid cancer	1.04e-06	0.00208	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.02e-06	0.00204	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—HPGD—thyroid cancer	9.92e-07	0.00199	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.87e-07	0.00198	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—RXRA—thyroid cancer	9.8e-07	0.00196	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CHST14—thyroid cancer	9.78e-07	0.00196	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CHST14—thyroid cancer	9.56e-07	0.00192	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.42e-07	0.00189	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	9.37e-07	0.00188	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MINPP1—thyroid cancer	9.24e-07	0.00185	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.11e-07	0.00182	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MINPP1—thyroid cancer	9.02e-07	0.00181	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.96e-07	0.00179	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—BRAF—thyroid cancer	8.75e-07	0.00175	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MINPP1—thyroid cancer	8.5e-07	0.0017	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MINPP1—thyroid cancer	8.43e-07	0.00169	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.29e-07	0.00166	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	7.96e-07	0.0016	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HPGD—thyroid cancer	7.88e-07	0.00158	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NDUFA13—thyroid cancer	7.86e-07	0.00157	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—TPR—thyroid cancer	7.8e-07	0.00156	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HPGD—thyroid cancer	7.71e-07	0.00154	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	7.67e-07	0.00154	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NDUFA13—thyroid cancer	7.67e-07	0.00154	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.65e-07	0.00153	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—RXRA—thyroid cancer	7.57e-07	0.00152	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CHST14—thyroid cancer	7.39e-07	0.00148	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NDUFA13—thyroid cancer	7.23e-07	0.00145	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CHST14—thyroid cancer	7.21e-07	0.00145	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MINPP1—thyroid cancer	7.2e-07	0.00144	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NDUFA13—thyroid cancer	7.17e-07	0.00144	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.13e-07	0.00143	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	7.13e-07	0.00143	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.01e-07	0.00141	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.96e-07	0.00139	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CHST14—thyroid cancer	6.8e-07	0.00136	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CHST14—thyroid cancer	6.74e-07	0.00135	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—TPR—thyroid cancer	6.67e-07	0.00134	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.6e-07	0.00132	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	6.56e-07	0.00131	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—TPR—thyroid cancer	6.18e-07	0.00124	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NDUFA13—thyroid cancer	6.12e-07	0.00123	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—TPR—thyroid cancer	6.12e-07	0.00123	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PRKAR1A—thyroid cancer	6.08e-07	0.00122	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	6.02e-07	0.00121	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HPGD—thyroid cancer	5.96e-07	0.00119	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.95e-07	0.00119	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	5.84e-07	0.00117	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HPGD—thyroid cancer	5.81e-07	0.00116	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CHST14—thyroid cancer	5.76e-07	0.00115	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—TPR—thyroid cancer	5.7e-07	0.00114	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.61e-07	0.00112	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	5.61e-07	0.00112	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.56e-07	0.00111	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HPGD—thyroid cancer	5.48e-07	0.0011	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.47e-07	0.0011	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HPGD—thyroid cancer	5.43e-07	0.00109	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.34e-07	0.00107	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.25e-07	0.00105	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.07e-07	0.00102	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	4.99e-07	0.001	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—RXRA—thyroid cancer	4.91e-07	0.000983	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.89e-07	0.00098	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.83e-07	0.000968	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.77e-07	0.000956	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.73e-07	0.000947	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.68e-07	0.000937	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HPGD—thyroid cancer	4.64e-07	0.00093	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—SLC5A5—thyroid cancer	4.62e-07	0.000926	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—SLC5A5—thyroid cancer	4.58e-07	0.000918	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—TPR—thyroid cancer	4.53e-07	0.000907	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.48e-07	0.000898	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	4.45e-07	0.000892	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CHST14—thyroid cancer	4.44e-07	0.00089	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—TPR—thyroid cancer	4.43e-07	0.000887	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.41e-07	0.000883	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	4.35e-07	0.000872	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—SLC5A5—thyroid cancer	4.27e-07	0.000855	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—RXRA—thyroid cancer	4.2e-07	0.000841	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.08e-07	0.000818	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—HRAS—thyroid cancer	4.02e-07	0.000806	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—RXRA—thyroid cancer	3.88e-07	0.000778	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—RXRA—thyroid cancer	3.85e-07	0.000771	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.77e-07	0.000754	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.76e-07	0.000753	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—RXRA—thyroid cancer	3.58e-07	0.000718	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPGD—thyroid cancer	3.58e-07	0.000718	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TPR—thyroid cancer	3.42e-07	0.000685	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.39e-07	0.000679	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.37e-07	0.000674	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TPR—thyroid cancer	3.34e-07	0.000669	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.34e-07	0.000669	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SLC5A5—thyroid cancer	3.31e-07	0.000664	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.29e-07	0.000658	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TPR—thyroid cancer	3.15e-07	0.00063	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TPR—thyroid cancer	3.12e-07	0.000625	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPARG—thyroid cancer	3.1e-07	0.000621	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	3.1e-07	0.00062	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.07e-07	0.000615	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.05e-07	0.000611	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—RXRA—thyroid cancer	2.85e-07	0.000571	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.82e-07	0.000565	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—RXRA—thyroid cancer	2.78e-07	0.000558	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.78e-07	0.000557	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TPR—thyroid cancer	2.67e-07	0.000534	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARG—thyroid cancer	2.65e-07	0.000531	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.62e-07	0.000525	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.56e-07	0.000513	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.5e-07	0.000501	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARG—thyroid cancer	2.45e-07	0.000491	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—thyroid cancer	2.44e-07	0.000488	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARG—thyroid cancer	2.43e-07	0.000487	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.4e-07	0.000481	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.38e-07	0.000476	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.36e-07	0.000472	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.34e-07	0.000468	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—thyroid cancer	2.26e-07	0.000453	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.19e-07	0.000438	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RXRA—thyroid cancer	2.15e-07	0.000431	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—thyroid cancer	2.13e-07	0.000426	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RXRA—thyroid cancer	2.1e-07	0.000421	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.09e-07	0.000419	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—thyroid cancer	2.08e-07	0.000418	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TPR—thyroid cancer	2.06e-07	0.000412	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.02e-07	0.000406	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2e-07	0.0004	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RXRA—thyroid cancer	1.98e-07	0.000397	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RXRA—thyroid cancer	1.96e-07	0.000393	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—thyroid cancer	1.93e-07	0.000387	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.91e-07	0.000383	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.91e-07	0.000382	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.87e-07	0.000375	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.82e-07	0.000364	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—thyroid cancer	1.8e-07	0.00036	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.78e-07	0.000357	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—thyroid cancer	1.76e-07	0.000352	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—thyroid cancer	1.68e-07	0.000337	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RXRA—thyroid cancer	1.68e-07	0.000336	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—thyroid cancer	1.67e-07	0.000334	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.63e-07	0.000327	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—thyroid cancer	1.55e-07	0.000311	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.54e-07	0.000309	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.41e-07	0.000283	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.38e-07	0.000277	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—thyroid cancer	1.36e-07	0.000272	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—thyroid cancer	1.33e-07	0.000266	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RXRA—thyroid cancer	1.29e-07	0.000259	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—thyroid cancer	1.25e-07	0.00025	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—thyroid cancer	1.24e-07	0.000248	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—thyroid cancer	1.23e-07	0.000247	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—thyroid cancer	1.22e-07	0.000245	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—thyroid cancer	1.21e-07	0.000242	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.07e-07	0.000214	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—thyroid cancer	1.06e-07	0.000212	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—thyroid cancer	1.05e-07	0.00021	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—thyroid cancer	1.04e-07	0.000209	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—thyroid cancer	9.83e-08	0.000197	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—thyroid cancer	9.75e-08	0.000195	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—thyroid cancer	9.7e-08	0.000194	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—thyroid cancer	9.61e-08	0.000193	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—thyroid cancer	9.32e-08	0.000187	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—thyroid cancer	9.1e-08	0.000182	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—thyroid cancer	8.95e-08	0.000179	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—thyroid cancer	8.57e-08	0.000172	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—thyroid cancer	8.5e-08	0.00017	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.33e-08	0.000167	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—thyroid cancer	8.17e-08	0.000164	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—thyroid cancer	7.26e-08	0.000146	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—thyroid cancer	7.11e-08	0.000142	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—thyroid cancer	6.95e-08	0.000139	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.43e-08	0.000129	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—thyroid cancer	5.61e-08	0.000112	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—thyroid cancer	5.37e-08	0.000108	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—thyroid cancer	5.24e-08	0.000105	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—thyroid cancer	4.94e-08	9.9e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—thyroid cancer	4.9e-08	9.81e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—thyroid cancer	4.19e-08	8.39e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—thyroid cancer	3.23e-08	6.47e-05	CbGpPWpGaD
